IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
91 hedge funds and large institutions have $1.08B invested in IGM Biosciences in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 24 increasing their positions, 35 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less call options, than puts
Call options by funds: $39.7M | Put options by funds: $43.6M
31% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 35
Holders
91
Holding in Top 10
1
Calls
$39.7M
Puts
$43.6M
Top Buyers
| 1 | +$50.8M | |
| 2 | +$20.8M | |
| 3 | +$14.6M | |
| 4 |
Alkeon Capital Management
New York
|
+$12.9M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$6.67M |
Top Sellers
| 1 | -$8.5M | |
| 2 | -$8.47M | |
| 3 | -$7.38M | |
| 4 |
BlackRock
New York
|
-$7.37M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$6.7M |